White Knight Strategic Wealth Advisors LLC Grows Position in The Clorox Company (NYSE:CLX)

White Knight Strategic Wealth Advisors LLC raised its position in The Clorox Company (NYSE:CLX) by 19.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,608 shares of the company’s stock after purchasing an additional 427 shares during the quarter. White Knight Strategic Wealth Advisors LLC’s holdings in Clorox were worth $425,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after buying an additional 4,490,421 shares during the period. Nuance Investments LLC increased its stake in Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the period. Van ECK Associates Corp lifted its position in shares of Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after purchasing an additional 120,716 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Clorox by 11.9% in the second quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company’s stock worth $109,483,000 after purchasing an additional 85,529 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CLX. Barclays lifted their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. DA Davidson lifted their target price on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft lifted their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, JPMorgan Chase & Co. increased their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Clorox presently has a consensus rating of “Hold” and a consensus price target of $155.00.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.57% of the stock is owned by corporate insiders.

Clorox Trading Down 0.0 %

Shares of Clorox stock opened at $167.14 on Friday. The firm’s 50 day simple moving average is $163.09 and its two-hundred day simple moving average is $149.32. The firm has a market capitalization of $20.69 billion, a price-to-earnings ratio of 58.24, a PEG ratio of 3.09 and a beta of 0.41. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.35. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 EPS. The firm’s revenue was up 27.0% on a year-over-year basis. Analysts predict that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. Clorox’s dividend payout ratio is currently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.